🇺🇸 FDA
Patent

US 8029826

Chlorite in the treatment of neurodegenerative disease

granted A61KA61K33/00A61K33/20

Quick answer

US patent 8029826 (Chlorite in the treatment of neurodegenerative disease) held by The Regents of the University of California expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K33/00, A61K33/20, A61K33/40, A61K47/02